Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Phase I and pharmacologic study of oral Ftorafur and x ray therapy in advanced gastrointestinal cancer

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

The authors have treated 15 patients with advanced gastrointestinal carcinoma with a cyclical regimen of combined Ftorafur (N/sub 1/-((2-furanidyl-))-5-Fluorouracil, a 5-FU pro-drug) and external beam radiation. The most common toxicity in general, and the most common limiting toxicity was nausea and vomiting, in contrast to oral FT alone where diarrhea is more prominent. Stomatitis was seen only once and no other form of serious toxicity was encountered. Two-thirds of the patients responded in subjective terms (pain relief). There was 1 partial response of FT alone (pulmonary metastases outside the treatment field). The sole patient whose treatment field was outside the abdomen (chest portals for esophageal carcinoma) developed pneumonitis which contributed to his death. No other delayed effects were noted. Serum FT levels were related to the infested dose and in the microgram range while serum 5-FU levels were in the nanogram range indicating slow decomposition of FT into 5-FU.

Research Organization:
Univ. of California, San Diego
OSTI ID:
5608534
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 11:3; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Pilot study of combination 5-fluorouracil, cisdiamminedichloroplatinum II, and radiation therapy for grade III and IV astrocytomas
Journal Article · Thu Oct 01 00:00:00 EDT 1987 · Am. J. Clin. Oncol.; (United States) · OSTI ID:5849640

Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiation
Journal Article · Sun Mar 31 23:00:00 EST 1985 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5518539

Phase II Study of Chemoradiotherapy With 5-Fluorouracil and Cisplatin for Stage II-III Esophageal Squamous Cell Carcinoma: JCOG Trial (JCOG 9906)
Journal Article · Tue Nov 01 00:00:00 EDT 2011 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:21590427